Table 3.

The comparative data from clinical trials on carotid atherosclerosis regression.

Trial	Medication	Mean annual IMT change, mm		Reference
		placebo	treatment
PLAC II	Pravastatin	0.068	0.059	Crouse J.R. et al., 1995 [48]
KAPS	Pravastatin	0.029	0.010	Salonen R. et al., 1993 [36]
ASAP	Simvastatin	-	−0.009	Smilde T.J. et al., 2001 [49]
PREVENT	Amlodipine	0.011	−0.015	Pitt B. et al., 2000 [50]
ASAP	Atorvastatin	-	−0.020	Smilde T.J. et al., 2001 [49]
CLAS	Cholestipol, niacin	0.010	−0.020	Blankenhorn D.H. et al., 1993; Hodis H.N., 1995; [51, 52]
MARS	Lovastatin	0.015	−0.028	Blankenhorn D.H. et al., 1993; Hodis H.N., 1995 [51, 53]
VHAS	Verapamil	-	−0.028	Zanchetti A. et al., 1998 [54]
AMAR	Allicor	0.015	−0.022	This study